TECH

AI Research

Ella platform receives EU CE-IVD marking; price target raised to $68 at Evercore ISI

Bio-Techne's Ella platform achieved CE-IVD marking and became available for sale in the EU on February 16, 2026, expanding its diagnostics and spatial biology reach. Q2 FY2026 revenue was flat YoY, with 1% organic growth in protein sciences and 3% in diagnostics and spatial biology, and adjusted operating margin improved 100bps to 31.1%. Evercore ISI raised its price target to $68 from $62 on February 5, 2026; the stock is trading at ~$51.05, down from the $68 target level.